SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003021
Filing Date
2017-04-28
Accepted
2017-04-28 06:57:32
Documents
6
Period of Report
2017-06-15
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231972zdef14a.htm DEF 14A 328909
2 G616421.JPG g616421.jpg GRAPHIC 20598
3 G412210.JPG g412210.jpg GRAPHIC 12600
4 G118902CAI001.GIF g118902cai001.gif GRAPHIC 121375
5 G118902CCI001.GIF g118902cci001.gif GRAPHIC 154276
6 G118902CEI001.GIF g118902cei001.gif GRAPHIC 58712
  Complete submission text file 0001047469-17-003021.txt   836731
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37508 | Film No.: 17791611
SIC: 2834 Pharmaceutical Preparations